SARS-CoV-2 transmission and the risk of aerosol-generating procedures

Susan Pasnick, W. Graham Carlos, Charles S. Dela Cruz, Jane E. Gross, Garth Garrison, Shazia Jamil

Research output: Contribution to journalArticle


The novel coronavirus SARS-CoV-2 was identified in China in December 2019. With evidence of global spread, it has become a pandemic. At the time of writing, COVID-19, the clinical syndrome caused by SARS-CoV-2, has claimed over 340,653 lives and stretched the capacity of healthcare systems around the world.1 The hallmark of severe COVID-19 is hypoxemic respiratory failure. Management of this condition historically involves procedures that have the potential to generate respiratory aerosols such as non-invasive ventilation and endotracheal intubation. ATS Patient Education Series

Original languageEnglish (US)
Pages (from-to)P13-P14
JournalAmerican journal of respiratory and critical care medicine
Issue number4
StatePublished - Aug 15 2020

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Fingerprint Dive into the research topics of 'SARS-CoV-2 transmission and the risk of aerosol-generating procedures'. Together they form a unique fingerprint.

  • Cite this